Runway Growth Finance Corp. (RWAY) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals several concerns: increased operational costs, credit downgrades, and a higher leverage ratio, all of which point to financial strain. Despite a new share repurchase program and the SWK acquisition's potential accretive impact, the negative outlook on earnings due to nonaccrual loans and reduced investment income overshadows positives. The NAV decline and portfolio depreciation further suggest a challenging environment. The Q&A does not alleviate these concerns, indicating a likely negative stock price movement in the next two weeks.
Key Financial Performance
Total Investment Income $29.5 million, a decrease compared to $30 million in the fourth quarter of 2025. The decrease was due to slower originations ahead of the SWK transaction close and elevated prepayments in the second half of 2025.
Net Investment Income $10.6 million, a decrease compared to $11.6 million in the fourth quarter of 2025. The decrease was attributed to the same factors affecting total investment income.
Fair Value of Total Investment Portfolio $886.3 million, a decrease of 4.4% from $927.4 million in the fourth quarter of 2025. The decrease was due to repayments and amortizations.
Net Assets $438.2 million, a decrease from $485 million in the fourth quarter of 2025. The decrease was influenced by transaction costs and portfolio adjustments.
NAV per Share $12.13, a decrease of 9.6% compared to $13.42 as of December 31, 2025. The decrease was primarily due to estimated transaction costs of $7.7 million related to the SWK acquisition.
Debt Portfolio Yield 14.2% for the first quarter of 2026, consistent with the fourth quarter of 2025 but declining from 15.4% in the same period last year. The decline was due to changes in portfolio composition.
Operating Expenses $18.8 million, an increase from $18.4 million in the fourth quarter of 2025. The increase was attributed to higher costs associated with the SWK transaction.
Net Realized Gain on Investments $1.3 million during the first quarter of 2026, compared to a realized loss of $380,000 during the fourth quarter of 2025. The gain was due to successful repayments and equity proceeds.
Leverage Ratio 0.98 as of March 31, 2026, compared to 0.90 at the end of the fourth quarter of 2025. The increase was due to the SWK transaction and portfolio adjustments.
Asset Coverage Ratio 2.02 as of March 31, 2026, compared to 2.11 at the end of the fourth quarter of 2025. The decrease was due to changes in portfolio composition and leverage.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
SWK transaction closing: Runway Growth Finance closed the SWK transaction, strengthening its position in healthcare and diversifying its portfolio. This acquisition has increased healthcare and life sciences exposure to 32% of the portfolio.
New investments: Runway completed a $7.5 million investment in HR Pharmaceuticals, funded $5.5 million at close, and provided $2 million in preferred equity financing. Additionally, a $46.3 million debt commitment was made to a digitally native fragrance brand, partially funded in Q2 2026.
Market dynamics: Despite scrutiny around software and AI disruption, the venture market shows resilience, particularly in early-stage investing and high-growth areas like AI. Runway Growth Finance remains confident in its ability to source high-quality investments.
Leadership changes: Several leadership changes were announced, including JD Tamas joining as Managing Director of Healthcare and Life Sciences Investing, Avisha Khubani promoted to Chief Credit Officer, and Carmela Thomson becoming CFO effective June 30, 2026.
Portfolio diversification: Post-SWK acquisition, the portfolio is more diversified with reduced average loan size by 11% and balanced exposure across technology, healthcare, financials, and consumer products.
Portfolio optimization: Runway Growth Finance is focusing on integrating the SWK portfolio and optimizing its portfolio for stronger long-term performance.
Share repurchase program: A new $15 million share repurchase program was announced, expiring May 7, 2027, to capitalize on attractive share valuation.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: Uncertainties surrounding interest rates and changing economic conditions could adversely impact the company's performance.
Portfolio Risk: Two loans, Marley Spoon and BlueShift, were moved to Category 5 and nonaccrual status, indicating potential credit issues and financial risks.
Net Asset Value (NAV) Decline: NAV per share decreased by 9.6% from $13.42 to $12.13, reflecting financial challenges and transaction costs.
Nonaccrual Loans Impact: The full quarter earnings impact of nonaccrual loans Marley Spoon and BlueShift is expected to reduce earnings by $0.06 per share in Q2.
Portfolio Diversification Challenges: Despite diversification efforts, the portfolio still faces risks from concentrated investments and sector-specific exposures.
Credit Downgrades: Recent credit downgrades of Marley Spoon and BlueShift highlight potential vulnerabilities in the portfolio.
Operational Costs: Total operating expenses increased to $18.8 million, adding pressure to financial performance.
Leverage Ratio Increase: Leverage ratio increased to 1.2x post-SWK transaction, indicating higher financial leverage and associated risks.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Portfolio Diversification and Growth: The company has reconstructed its portfolio with a focus on diversification, particularly in the healthcare and life sciences sectors, which now comprise 32% of the portfolio. This is expected to enhance future earnings power and provide a balanced mix of investments across technology, financials, healthcare, and select consumer products and services.
Future Investment Strategy: Runway Growth Finance plans to capitalize on a robust pipeline of high-quality investments in core sectors such as technology, healthcare, and select consumer products and services. The company is optimistic about sourcing high-quality late-stage software investments characterized by mission-critical functions and strong competitive moats.
Impact of SWK Acquisition: The acquisition of SWK Holdings is expected to contribute positively to the portfolio's return profile over the balance of the year. The integration of the SWK portfolio is anticipated to drive stronger outcomes for both borrowers and shareholders.
Dividend and Share Repurchase Program: The company declared a regular distribution for the second quarter of 2026 of $0.33 per share and announced a new $15 million share repurchase program, which will expire on May 7, 2027. Repurchases are expected to be partly funded by proceeds from loan repayments in the coming quarters.
Financial Projections: Net investment income (NII) is expected to benefit by approximately $0.03 per share from the fully integrated SWK portfolio in the next quarter. However, this benefit may be offset by the impact of nonaccrual loans, which are expected to have a full-quarter earnings impact of $0.06 per share in Q2 2026.
Market Trends and Opportunities: The company sees resilience in early-stage investing and sustained interest in high-growth areas like AI. It believes its portfolio companies are well-positioned to leverage AI to optimize operations and accelerate market penetration.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Base Dividend: $0.33 per share for the first quarter of 2026.
Spillover Income: Approximately $0.65 per share.
Future Dividend Outlook: The Board continues to evaluate future distributions with the goal of maintaining consistency while maximizing returns.
Second Quarter Dividend: A regular distribution of $0.33 per share was declared for the second quarter of 2026.
Share Repurchase Program: A new share repurchase program for $15 million was announced, expiring on May 7, 2027.
Funding for Repurchases: Repurchases are expected to be partly funded by proceeds from loan repayments in the coming quarters.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What were the one-time expenses recorded in the quarter related to the SWK acquisition and accelerated debt expense?
A:There was about $0.02 or $0.03 related to the early redemption of baby bonds. No direct SWK expenses were recorded as most were capitalized into the transaction. Any personnel allocation changes were minimal and considered a rounding error.
Q:How does the company evaluate the use of capital between investing in new portfolio companies and buying back shares?
A:The company balances between the two by considering the excess borrowing base and leverage ratio. They prioritize deals with the best risk-return trade-off, focusing on higher-yielding, smaller-sized transactions within stated risk parameters.
Q:What was the driver for the unrealized depreciation charges?
A:The changes in fair value impacting NAV were primarily due to declines in market multiples (about 1/3) and issues with watchlist names, mainly BlueShift and Marley Spoon.
Q:What is the estimated drag on earnings from BlueShift and Marley Spoon?
A:The drag on earnings from these two is roughly $0.06 per quarter. The watchlist includes six names, with some marked at 50%. Workouts for these assets will take varying times to resolve.
Q:When is the SWK acquisition expected to be accretive to EPS?
A:The SWK acquisition is expected to be partially accretive to EPS in Q2 and fully accretive in Q3, as the transaction closed on April 6 instead of March 31.
Q:Review of Unclear Management Responses
A:None of the questions appeared to be avoided or lacked clarity in the responses provided by management.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI market
CFO COO
Carmela
Director
Finance Accounting
Partners Credit
SWK portfolio
SWK transaction
acquisition
adviser
appointment
approach software
care life
closing SWK
cycle
day
diligence
effort
experience
expertise
firm
fundamental
health care
investing
level capital
life science
platform
portfolio construction
position
quality stage
resilience
role BDC
software investment
tandem
understanding
RWAY Transcript
Runway Growth Finance Corp. (RWAY) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call reveals several concerns: increased operational costs, credit downgrades, and a higher leverage ratio, all of which point to financial strain. Despite a new share repurchase program and the SWK acquisition's potential accretive impact, the negative outlook on earnings due to nonaccrual loans and reduced investment income overshadows positives. The NAV decline and portfolio depreciation further suggest a challenging environment. The Q&A does not alleviate these concerns, indicating a likely negative stock price movement in the next two weeks.
Runway Growth Finance Corp. (RWAY) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call reveals several negative financial trends: a decline in total investment income, net investment income, and portfolio value. While the acquisition of SWK Holdings and strategic plans are positive, the immediate financial performance is weak. The Q&A highlights cautious sentiment regarding leverage and challenges in building the Cadma JV portfolio. Although there are some positive developments, such as improved investment outcomes and strong liquidity, the overall sentiment is dampened by declining income and NAV, resulting in a negative outlook.
Runway Growth Finance Corp. (RWAY) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary indicates a positive sentiment overall, with strong financial performance, optimistic product development updates, and a shareholder return plan involving a stock repurchase program. Despite some muted market outlooks and competitive pressures, the Q&A section reflects a positive sentiment from analysts, especially regarding the SWK merger's accretive potential. The strategic plan and capital management efforts further support a positive outlook for the stock price in the short term.
Runway Growth Finance Corp. (RWAY) Q2 2025 Earnings Call Transcript
Unknown8-8
The earnings call shows mixed signals: strong liquidity and shareholder returns are positive, but there's a decrease in NAV per share and asset coverage. The Q&A reveals cautious management, with concerns over increased interest expenses and unclear guidance on JV benefits. Despite some positive developments like new products and strategic partnerships, the muted deal activity and management's cautious outlook suggest limited short-term stock price movement. Overall, these factors balance out, resulting in a neutral sentiment.
RWAY Slides
Runway Growth Q1 2026 slides: earnings miss amid SWK integration2026-05-07
Runway Growth Q4 2025 slides highlight expansion amid revenue miss2026-03-12
Runway Growth Finance Q3 2025 slides: Strategic acquisitions to boost portfolio amid yield compression2025-11-06
Runway Growth Finance Q2 2025 slides: portfolio stability and NAV growth amid market challenges2025-08-07
RWAY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
